Indications and uses
relieves occasional constipation (irregularity) generally causes bowel movment in 6 to 12 hours
relieves occasional constipation (irregularity) generally causes bowel movment in 6 to 12 hours
shake well before use Do not exceed recommended dose Age Starting Dose Maximum dosage Adults and children 12 years and older 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor 3 teaspoons in the morning and 3 teaspoons at bedtime Under 12 years of age ask a doctor ask a doctor Other information store at room temperature 20° to 25°C (68° to 77°F). a brown, natur...
(per teaspoonful - 5 mL)
Sennosides - 8.8 mg
Laxative
Do not use
Ask a doctor or pharmacist before use if you have
Stop use and ask a doctor if
you have rectal bleeding or failure to have a bowel movemebt after use of laxative. They may indicate a serious condition.
ask a health professional before use.
In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
| Age | Starting Dose | Maximum dosage |
| Adults and children 12 years and older | 2-3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor | 3 teaspoons in the morning and 3 teaspoons at bedtime |
| Under 12 years of age | ask a doctor | ask a doctor |
Other information
NDC 0121-4967-05: 5 mL unit dose cup, in a tray of ten cups.
NDC 0121-4967-40: Case contains 40 unit dose cups of 5 mL (0121-4967-05) packaged in 4 trays of 10 unit dose cups each.
citric acid, glycerin, methylparaben, potassium sorbate, propylparaben, purified water, and sucrose.
1-800-845-8210
Pharmaceutical Associates, Inc.
Greenville, SC 29605
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 7 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 7 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 7 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 7 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 7 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-4967-05 | Senna | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 7 | |
| 0121-4967-40 | Senna | 10 in 1 TRAY | LIQUID | 10 | 7 | |
| 0121-4967-40 | Senna | 4 in 1 CASE | LIQUID | 4 | 7 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-4967-05 | ML - Milliliter | 0121-4967 | 967b07b3-40f5-45ac-891a-3431f3146660 | 1 | 2022-04-06 |
| 0121-4967-40 | ML - Milliliter | 0121-4967 | 772566ca-c6fd-45fe-bcca-75122be4955d | 1 | 2022-04-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0121-4967 | 0121-4967-05, 0121-4967-40 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CITRIC ACID ACETATE | DSO12WL7AU | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SUCROSE | C151H8M554 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna | SENNOSIDES | PAI Holdings, LLC dba PAI Pharma | 7c28ffb8-149f-4a5a-ab98-dfa7b3b0f6ed | 2025-04-28 | Warnings | 0121-4967-05 0121-4967-40 0121-4967 00121496705 00121496740 788bfeed-afae-42ae-a24b-0634f35f000b 7c28ffb8-149f-4a5a-ab98-dfa7b3b0f6ed |
Adverse event summaries are temporarily unavailable. Other product information remains available.